Clinical Trial Update: RESistance of IgA Nephropathy to Conventional and Newly-approved Therapies: an Observational, Real-life Study (RESIGAN)

View source ↗

Summary

An observational, real-world study called RESIGAN evaluating resistance of IgA nephropathy to conventional and newly approved therapies; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: IgA Nephropathy (IgAN) | Status: RECRUITING